Company Overview and News

 
Lockheed Martin Wins $928M Hypersonic Strike Weapon Contract

17h zacks
Lockheed Martin Corp.’s (LMT - Free Report) segment, Space Systems, recently secured a $928-million modification contract for the development of hypersonic conventional strike weapon. The contract was awarded by the Air Force Life Cycle Management, Eglin Air Force Base, Florida. Details of the Deal Per the terms, Lockheed Martin will offer the design, engineering, systems integration, test, logistics planning, and aircraft integration support of all the elements of a hypersonic, conventional, air-launched, stand-off weapon.
Upvote Downvote

 
5 Stocks With Low Debt-to-Equity Ratio Worth Betting On

2018-04-18 investorplace
Debt financing – a well know business strategy in the corporate finance space – refers to borrowing of money, mostly by selling debt instruments to individuals or institutional investors. Per the theory of cost of capital, a company’s capital structure reflects a mix of debt and equity that is used to finance its capital projects.
Upvote Downvote

 
Raytheon Wins $83M Barracuda Mine Neutralization System Deal

2018-04-18 zacks
Raytheon Company (RTN - Free Report) recently secured an $83.3 million contract from the Federal Business Opportunities website for designing, testing and deploying the Barracuda mine neutralization system. The contract was awarded by the Naval Sea Systems Command, Washington, DC. Majority of operations related to the deal will be carried out in Portsmouth, RI and in DeLeon Springs, FL. Raytheon will utilize fiscal 2017 and 2018 research, development, test and evaluation (Navy) funds to partially finance the task.
Upvote Downvote

 
Lockheed Martin Wins $200M Deal to Upgrade THAAD and PATRIOT

2018-04-18 zacks
Lockheed Martin Corp. (LMT - Free Report) recently secured a $200-million modification contract for enhancing the Terminal High Altitude Area Defense (THAAD) and Phased Array Tracking to Intercept of Target (PATRIOT) Advanced Capability-3 (PAC-3) missile segment. Per the terms, Lockheed Martin will also help to develop Patriot's Launch on Remote (LOR). The contract was awarded by the U.S. Army Contracting Command, Redstone Arsenal, Alabama.
Upvote Downvote

 
5 Stocks With Low Debt-to-Equity Ratio Worth Betting On

2018-04-18 zacks
Debt financing – a well know business strategy in the corporate finance space – refers to borrowing of money, mostly by selling debt instruments to individuals or institutional investors. Per the theory of cost of capital, a company’s capital structure reflects a mix of debt and equity that is used to finance its capital projects. Now a comparative analysis of the same theory reveals that most companies prefer debt financing over equity since debt is cheaper, especially in periods of low interest rates.
Upvote Downvote

 
Curtiss-Wright Awarded $85 M to Support US Navy's Ford-Class Aircraft Carrier Program

2018-04-18 asdnews
Curtiss-Wright Corporation (NYSE: CW) today announced that it has been awarded a contract valued in excess of $85 million to provide main propulsion steam turbines and auxiliary equipment for the U.S. Navy’s Ford-class aircraft carrier Enterprise (CVN 80). The award was received from Huntington Ingalls, Newport News Shipbuilding (HII-NNS) to support planned ship construction.
Upvote Downvote

 
Embraer's (ERJ) Q1 Deliveries Decline Y/Y, Backlog Slips

2018-04-17 zacks
Embraer S.A. (ERJ - Free Report) recently reported its delivery figures for the first quarter of 2018. Total number of jets delivered in the reported quarter was 25, marking a decline of 24.2% from the year-ago quarter’s figure of 33 jets. Q1 Deliveries & Backlog Embraer delivered a total of 14 jets in the first quarter 2018, in the commercial aviation market, compared to 18 jets delivered in the prior-year’s first quarter.
Upvote Downvote

 
Raytheon (RTN) Hits Fresh Highs: Is There Still Room to Run?

2018-04-17 zacks
Have you been paying attention to shares of Raytheon Company (RTN - Free Report) ? Shares have been on the move with the stock up 6.8% over the past month. RTN hit a new 52-week high of $225.86 in the previous session. Raytheon has gained 19.8% since the start of the year compared to the 10.2% move for the Aerospace sector and the 9.5% year-to-date return for its peer group.
Upvote Downvote

 
Can TransDigm Maintain Impressive Momentum Amid Risks?

2018-04-16 zacks
TransDigm Group Inc. (TDG - Free Report) has managed to impress investors with its recent earnings streak, wherein the company’s bottom line has trumped estimates thrice in the trailing four quarters. TransDigm’s impressive business model actively works toward strengthening and enhancing its position in highly-engineered proprietary aerospace components’ niche markets.
Upvote Downvote

 
General Dynamics (GD) Wins $144M US BICES-X Maintenance Deal

2018-04-16 zacks
General Dynamics Corp.’s (GD - Free Report) subsidiary, General Dynamics Mission Systems, recently secured a $144-million contract for the operation, maintenance and expansion of the global U.S. Battlefield Information Collection and Exploitation System Extended (US BICES-X) federated trusted network environment infrastructure. Operations related to the deal will be carried out across multiple locations globally.
Upvote Downvote

 
Boeing, Lion Air Group Ink $6.2B Deal for 50 737 MAX 10 Jets

2018-04-12 zacks
The Boeing Company (BA - Free Report) recently secured a contract to deliver 50 new 737 MAX 10 aircraft to the Lion Air Group. The deal, worth $6.24 billion at current list prices, will become the airlines’ largest order of the MAX 10 variant to date. The order is expected to enable Lion Group optimize its network and increase profitability. A Brief Note on 737 MAX Boeing’s 737 MAX family of airplanes incorporate the latest CFM International LEAP-1B engines, Advanced Technology winglets, the Boeing Sky Interior and large flight deck displays.
Upvote Downvote

 
Boeing (BA) Q1 Commercial Deliveries Up Y/Y, Defense Slips

2018-04-11 zacks
The Boeing Company (BA - Free Report) recently announced the program deliveries across its commercial and defense operations for the first quarter of 2018. The figures show an 8.9% rise in commercial shipments and 40.5% decline in defense shipments from the previous year. Q1 Orders & Deliveries Boeing reported first-quarter 2018 commercial deliveries of 184 airplanes, up year over year primarily backed by higher demand for 737 jets.
Upvote Downvote

 
Lockheed Martin's Unit Wins $80M Missile Deal From US Navy

2018-04-10 zacks
Lockheed Martin Corp.’s (LMT - Free Report) unit, Rotary and Mission Systems (“RMS”), recently secured an $80-million modification contract to exercise option for Multi-Mission Signal Processor; Ballistic Missile Defense Kill Assessment System 5.1; and AEGIS AMOD Upgrade for DDG-85, DDG-87 and DDG-88. The contract was awarded by the Naval Sea Systems Command, Washington, D.C. Operations related to the deal will be carried out in Moorestown, NJ; Clearwater, FL and Owego, NY.
Upvote Downvote

 
Boeing Wins F-15SA Deal for Cumulative Face Value of $305M

2018-04-10 zacks
The Boeing Company (BA - Free Report) recently secured a modification contract worth $50 million for original equipment manufacturing of (OEM) Royal Saudi Air Force F-15SA fighter jet. Work related to this deal is expected to be over by Aug 6, 2019.
Upvote Downvote

 
Boeing, American Airlines Ink $12B Deal for 47 Dreamliners

2018-04-09 zacks
The Boeing Company (BA - Free Report) recently secured a contract to deliver 47 787-Dreamliner aircrafts to American Airlines, the world’s largest airline. Per the terms, the airline will recieve 22 787-8 and 25 787-9 Dreamliners from Boeing to expand and modernize its fleet. This deal is expected to open new routes for American Airlines across the globe, including Europe and Asia Pacific region. The deal is valued at more than $12 billion at current list prices and will make the airline Boeing’s largest 787-Dreamliner customers in Western Hemisphere.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 231561101